Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq in liver cancer cell and cinobufagin treatment cells

ABSTRACT: RNA-seq in liver cancer cell and cinobufagin treatment cells

PROVIDER: PRJNA597601 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10765867.fastq.gz	Fastqsanger.gz
	SRR10765868.fastq.gz	Fastqsanger.gz
	SRR10765869.fastq.gz	Fastqsanger.gz
	SRR10765870.fastq.gz	Fastqsanger.gz
	SRR10765871.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

RNA-seq in liver cancer cell and cinobufagin treatment cells

Project description:Cinobufagin, belonged to a kind of cardiotonic steroids (CSs), derived from the extracts of toad venom, which presented the significant anticancer properties as inhibitors of Na+/K+-ATPase (NKA) in many cancer cells. Nowadays, cinobufagin was usually used to apply for clinical treatments of patients in advanced stage of cancer, and improved their quality of life and prolonged their survival period. Unfortunately, long-term drug treatment had also led to multi-drug-resistance (MDR) likely other chemotherapy drugs. However, this detailed mechanism was not still clear. In the present study, we noticed that cinobufagin could trigger the protective autophagy to suppress cells apoptosis in liver cancer HepG2 and Huh-7 cells by inhibition of PI3K-AKT-mTOR pathway using RNA-seq method. We also confirmed that cinobufagin could inhibit cells proliferation and induce cells apoptosis, and generated cells autophagy by up-regulation expression of LC3B-II, Beclin 1 and Atg12-atg5. More importantly, autophagy inhibitor (MRT68921) enhances the anti-proliferation and pro-apoptosis effects of cinobufagin in HCC cells. Therefore, we thought that a combination of cinobufagin and autophagy inhibitors may be a potential effective strategy in treatment of HCC.

2019-12-26 | GSE142588 | GEO

Kinetics after JQ1 treatment in liver cancer cell

Project description:Analysis of global gene expression after BRD4 inhibition by JQ1 in liver cancer cell lines SK-Hep1 Total RNA obtained from human liver cancer cell line SK-Hep1 cells after treatment of JQ1

2016-07-20 | E-GEOD-75908 | biostudies-arrayexpress

Effect of Romidepsin treatment on patient-derived liver cancer cells

Project description:Effect of Romidepsin treatment on patient-derived liver cancer cells

| PRJNA946751 | ENA

Sequencing of liver cancer cell lines

Project description:Liver cancer is a dreadful disease with limited therapeutic options. How to translate genomic findings into biomarkers and precision treatment is challenging. A large cell line-based platform was established, termed as Liver Cancer Model Repository. Heterogeneities in patients were faithfully recapitulated by 81 liver cancer cell lines at genomic and transcriptomic levels. This platform provides a rich resource and models to study cancer drivers and drug responses in liver cancer.

| EGAS00001002237 | EGA

RNA-seq of liver tissue and liver cancer cell lines

Project description:RNA-seq of liver tissue and liver cancer cell lines

| PRJEB11781 | ENA

Investigate A2M treatment on human prostate cancer and mouse liver

Project description:Investigate A2M treatment on human prostate cancer and mouse liver

| PRJNA419249 | ENA

Kinetics after JQ1 treatment in liver cancer cell

Project description:Analysis of global gene expression after BRD4 inhibition by JQ1 in liver cancer cell lines SK-Hep1

2016-07-20 | GSE75908 | GEO

Liver array following CMPF treatment

Project description:Liver array following CMPF treatment

| PRJNA417491 | ENA

Expression data of tigecycline-treated liver cancer cells

Project description:Treatment of advanced liver cancer still faces great challenges. Identification of tumor dependencies is important for developing novel therapeutic strategies for liver cancer. Here, we identified mitochondrial translation as a major vulnerability of liver cancer by genome-wide CRISPR screen. Targeting mitochondrial translation by tigecycline showed therapeutic potential in liver cancer. While some liver cancer cells were extremely insensitive to tigecycline.Thus,RNA sequencing was performed to explore mechanisms.

2022-04-26 | GSE199842 | GEO

SMARCB1 knockdown in liver cancer cells

Project description:SMARCB1 knockdown in liver cancer cells

| PRJNA419313 | ENA